OMOLOLA ADEYEMI: Open Payments
NPI 1689389629 · BLOOMINGDALE, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$197 in 6 payments from 3 companies in 2025. Trend: 2023 $174 · 2024 $311 · 2025 $197
Food & beverage: $197
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc | 2 | $101 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $69 |
| ABBVIE INC. | 1 | $26 |
Products named: INVEGA SUSTENNA, CAPLYTA, VRAYLAR.
Industry payments across IL — which companies pay providers there.
